Innovent and Roche Partner to Advance Novel DLL3-Targeted ADC, IBI3009

Innovent Biologics, a top-tier biopharmaceutical firm focused on creating, producing, and marketing high-quality drugs for oncology, cardiovascular and metabolic diseases, autoimmune disorders, ophthalmology, and various other serious illnesses...

Akums Unveils New Sterile Facility for Lyophilised Products and Injectables

Akums Drugs and Pharmaceuticals revealed the launch of a new sterile facility focused on manufacturing lyophilised products and injectables, alongside vials, ampoules, eye and ear drops, and form-fill-seal (FFS) products. Lyophilisation involves...

India Leads in Vaccine Production, Hosts 2nd Largest USFDA Plants

India now represents 60% of worldwide vaccine production and hosts the second-highest number of USFDA-approved manufacturing facilities outside the United States. As investment prospects expand in areas like Bio-Pharma, Bio-Agri, Bio-Industrial...

Indian Pharma Sees Fewer USFDA Adverse Outcomes in 2024

Indian pharmaceutical firms have achieved significant progress in complying with rigorous US Food and Drug Administration (USFDA) standards in 2024, with evidence indicating a reduction in adverse classification results from inspections involving...

India Opens its First Dedicated MedTech Park in Vishakapatnam

The Andhra Pradesh MedTech Zone (AMTZ), established as India's first dedicated medical technology park in Visakhapatnam, has emerged as a vital hub in the global medical technology ecosystem, according to its Managing Director and founder CEO, Jit...

Chhattisgarh Positioning itself as Newest Pharmaceutical Hub of India

Chhattisgarh is positioning itself as a new pharmaceutical centre in central India, with the Naya Raipur Atal Nagar Development Authority allocating 141.84 acres in Sector-22 to foster research, development, and international investment in pharma...

Mankind Pharma to Produce Immunotherapy Medicines with Innovent Biologics

Mankind Pharma Limited and Innovent Biologics have announced partnership to exclusively license and commercialize sintilimab, an advanced PD-1 immunotherapy, in the Indian market. This strategic collaboration aims to address the critical challenge...

India's Medical Device Exports Rise 14% CAGR to $3.8 Billion in FY24

India’s medical devices exports rose at a CAGR of 14% from FY20 to reach reach $3.8 billion in FY24. However, the country continues to remain a net importer of medical devices, bringing in 80-85% of its domestic requirements from abroad...

Driving Innovation and Sustainability in Packaging Successfully Concludes

The 2nd edition of Pack.Nxt 2024 concluded successfully at The Lalit, Mumbai, bringing together industry pioneers, policymakers, and sustainability advocates to explore the theme "Smart | Circular | Sustainable."

Pharmaceutical Water Market Rises on High-Quality Demand

The market for pharmaceutical water is propelled by the increasing need for premium-quality pharmaceutical water in various uses, including parenteral solutions, intravenous fluids, and active pharmaceutical ingredients (APIs). Tight regulations...

© 2025 India Pharma Outlook. All Rights Reserved.

Safety Monitoring